MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202641110140 A) filed by Vellore Institute Of Technology on September 14, 2026, for Mettl1 Inhibition Via Repurposed Ketoconazole As A Shared Therapeutic Strategy For Alzheimer'S And Huntington'S Diseases: An In Silico Study.
Inventors include Devi Rajeswari V; Ansh Bahri; Divyanshi Gupta; and Soumik Das.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The present invention relates to a computer-implemented method for identifying and validating repurposable therapeutic candidates common to Alzheimer's disease and Huntington's disease. Multiple independent transcriptomic datasets are subjected t...